HIST1H4A (Ab-88) Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to HIST1H4A (Ab-88) Antibody

The HIST1H4A (Ab-88) Antibody is a polyclonal antibody targeting the tyrosine 88 (Y88) residue of human histone H4, a core component of nucleosomes. Histone H4 plays a central role in chromatin structure, gene regulation, and epigenetic modifications such as acetylation and methylation . This antibody is specifically designed to study post-translational modifications (PTMs) at this site, which influence DNA accessibility and cellular processes like transcription and DNA repair .

Immunohistochemistry (IHC)

  • Detects histone H4 modifications in formalin-fixed, paraffin-embedded human tissues .

  • Example: Staining of breast adenocarcinoma sections showed nuclear localization, validated using EDTA antigen retrieval and HRP-conjugated secondary antibodies .

Immunofluorescence (IF)

  • Compatible with cell lines like HeLa, with optimal results at dilutions of 1:50–1:500 .

  • Nuclear DNA co-staining with DAPI confirms specificity .

ELISA

  • Quantitative detection range: 37.5–2400 pg/mL in serum, plasma, or cell lysates .

  • Recovery rates: 89–115% in human serum and plasma .

Comparative Analysis with Other Histone H4 Antibodies

FeatureHIST1H4A (Ab-88)Histone H4 (acetyl K8)Histone H4 (tri-methyl K20)
Target ModificationPhosphorylated Y88Acetylated K8Tri-methylated K20
ClonalityPolyclonal Monoclonal (ab45166) Monoclonal (M14495)
ApplicationsIHC, IF, ELISA ChIP, WB, Flow Cytometry WB, IHC, ChIP
Species ReactivityHuman Human, Mouse, Rat Human, Mouse, Rat

Validation and Quality Control

  • Specificity: Blocking experiments with Y88-containing peptides confirm minimal cross-reactivity .

  • Batch Consistency: Antigen affinity purification ensures high lot-to-lot reproducibility .

  • Negative Controls: PBS instead of primary antibody or isotype-matched IgG showed no background staining .

Technical Considerations

  • Antigen Retrieval: EDTA buffer (pH 9.0) recommended for IHC .

  • Buffer Optimization: Use 5% non-fat dry milk/TBST for blocking to reduce non-specific binding .

  • Limitations: Not validated for flow cytometry or chromatin immunoprecipitation (ChIP) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your orders. Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery times.
Synonyms
Histone H4, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, H4/A H4FA, H4/I H4FI, H4/G H4FG, H4/B H4FB, H4/J H4FJ, H4/C H4FC, H4/H H4FH, H4/M H4FM, H4/E H4FE, H4/D H4FD, H4/K H4FK, H4/N H4F2 H4FN HIST2H4, H4/O H4FO
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of the nucleosome. Nucleosomes wrap and compact DNA into chromatin, thereby limiting DNA accessibility to the cellular machineries that require DNA as a template. Consequently, histones play a crucial role in transcription regulation, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated through a complex set of post-translational modifications of histones, known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Studies have shown that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Research suggests that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac upon DNA double-strand break. SETD2, LEDGF, and KAT5 are essential for these epigenetic changes. (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5) PMID: 28546430
  3. Data reveal that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be associated with an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines corresponds to increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Data indicate that G1-phase histone assembly is restricted to CENP-A and H4. PMID: 23363600
  10. This study focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers function as major nuclear proteins whose binding of histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to an epigenetic mechanism involving suppression of acetylation of histone H4. PMID: 21973049
  13. Research suggests that global histone H3 and H4 modification patterns are potential markers of tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47, catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing association of CAF-1 with H3.1-H4. PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4 modification. PMID: 20949922
  17. Findings reveal the molecular mechanisms whereby the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which in turn, reduces gene expression by half. PMID: 20512922
  18. Expression is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, potentially through alteration of gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation levels of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. There is a relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation play novel roles in mediating recruitment of multiple regulatory factors that can change chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are important for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more common in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Findings indicate an important role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results indicate, by acetylation of histone H4 K16 during S-phase, early replicating chromatin domains acquire the H4K16ac-K20me2 epigenetic label that persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the next cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play a significant role in innate immunity. PMID: 19536143
  37. Histone modification, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36, two marks of elongation within genes, when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is HIST1H4A and what is the significance of the Tyr88 phosphorylation site?

HIST1H4A is a histone H4 family member that plays critical roles in chromatin structure and gene regulation. The tyrosine 88 (Tyr88) residue in histone H4 is evolutionarily conserved, suggesting an important physiological function . Phosphorylation at this site (pY88-H4) has been identified in multiple castration-resistant prostate cancer (CRPC) biospecimens, indicating its potential role in disease progression . This post-translational modification appears to be involved in regulating androgen receptor (AR) gene expression, making it particularly relevant for prostate cancer research .

How is the specificity of HIST1H4A (Ab-88) Antibody validated?

The specificity of HIST1H4A (Ab-88) Antibody is validated through multiple complementary approaches:

  • Peptide competition assays - The antibody specifically recognizes Tyr88-phosphorylated H4 peptide but not unphosphorylated peptide

  • Cross-reactivity screening - Testing against 59 different histone modifications (acetylation, methylation, phosphorylation, and citrullination) using Histone Peptide Array demonstrates no cross-reactivity

  • Mutation studies - Point mutant constructs (Y88F-H4 and Y72F-H4) confirm that the antibody specifically recognizes phosphorylation at the Tyr88 site but not at Tyr72

  • Western blotting - Direct immunoblotting and immunofluorescence analyses further validate specificity

What sample preparation protocols are recommended for histone H4 phosphorylation detection?

For optimal detection of histone H4 phosphorylation at Tyr88, the following protocols are recommended:

  • Histone Purification: Total histones should be purified from cells or tissues using acid extraction methods

  • Cell Treatment: For stimulation studies, serum and androgen starvation followed by growth factor treatment (e.g., insulin-like growth factor or platelet-derived growth factor) can induce robust phosphorylation

  • Protein Extraction: For immunoblotting applications, standard cell lysis and nuclear extraction protocols are appropriate with the addition of phosphatase inhibitors to preserve phosphorylation status

  • ChIP Sample Preparation: For chromatin immunoprecipitation applications, standard crosslinking procedures followed by sonication to generate chromatin fragments of appropriate size (~200-500bp) are recommended

How can HIST1H4A (Ab-88) Antibody be effectively used in ChIP-seq experiments?

HIST1H4A (Ab-88) Antibody has been successfully employed in ChIP-seq experiments to map the genome-wide distribution of pY88-H4 marks. Based on published research methodologies:

  • Immunoprecipitation Protocol: The antibody can be used to immunoprecipitate chromatin fragments containing the pY88-H4 mark

  • Sequencing Depth: For comprehensive coverage, high-depth sequencing is recommended (~20-30 million uniquely mapped reads)

  • Data Analysis: The resulting data can identify distinct genomic locations where pY88-H4 marks are deposited (e.g., upstream of the AR transcription start site)

  • Validation: ChIP-qPCR with site-specific primers should be used to validate key findings from ChIP-seq data

Research using this approach has identified approximately 370 distinct genomic locations with pY88-H4 deposition, including specific regions upstream of the AR gene that appear critical for its transcriptional regulation .

What is the relationship between ACK1 kinase and histone H4 Tyr88 phosphorylation?

Evidence from multiple experimental approaches demonstrates that ACK1 (TNK2) is the primary kinase responsible for phosphorylating histone H4 at Tyr88:

  • Mass Spectrometry Analysis: Total histones purified from cells expressing activated ACK1 show Tyr88 phosphorylation, while histones from SRC-expressing cells do not

  • Protein Interaction: Pull-down studies followed by mass spectrometry reveal that ACK1 (phosphorylated at Tyr827) binds directly to histone H4

  • In Vitro Kinase Assay: Purified recombinant human ACK1 directly phosphorylates histone H4 at Tyr88 in cell-free conditions, and this activity is inhibited by ACK1 inhibitor (R)-9bMS

  • Specificity Testing: When incubated with all four core histones, ACK1 specifically phosphorylates H4 but not H2A, H2B, or H3

  • Knockdown Studies: siRNA-mediated knockdown or CRISPR-Cas9 deletion of ACK1 significantly reduces H4 Tyr88 phosphorylation

Experimental ApproachKey FindingReference
Mass SpectrometryACK1 but not SRC induces pY88-H4
Protein Pull-downPhosphorylated ACK1 binds H4
In Vitro Kinase AssayPurified ACK1 directly phosphorylates H4
Specificity TestingACK1 phosphorylates H4 but not other core histones
Genetic ManipulationACK1 knockdown reduces pY88-H4 levels

How does pY88-H4 contribute to gene regulation and what are the implications for disease?

The phosphorylation of histone H4 at Tyr88 appears to play a critical role in gene regulation, particularly for the androgen receptor (AR) gene:

  • Chromatin Marking: ChIP-seq analysis reveals that pY88-H4 marks are deposited at specific locations upstream of the AR transcription start site, termed AR enhancer modules (AREMs)

  • Transcriptional Activation: The deposition of pY88-H4 marks is associated with increased AR gene expression

  • Mechanism: The pY88-H4 mark appears to promote recruitment of the WDR5/MLL2 complex, which likely contributes to transcriptional activation

  • Functional Consequence: Mutation studies using the Y88F mutant of H4 demonstrate that this phosphorylation site is necessary for AR upregulation, as expression of the non-phosphorylatable mutant results in decreased AR and PSA mRNA levels

  • Disease Relevance: The pY88-H4 mark has been identified in castration-resistant prostate cancer samples but not in normal prostate tissue, suggesting its potential role in disease progression

What controls should be included when using HIST1H4A (Ab-88) Antibody in experiments?

To ensure robust and reproducible results when using HIST1H4A (Ab-88) Antibody, the following controls should be included:

  • Peptide Competition: Pre-incubation of the antibody with phosphopeptide should abolish signal

  • Kinase Inhibition: Treatment with ACK1 inhibitor ((R)-9bMS) should reduce pY88-H4 signal

  • Genetic Controls: Cells expressing Y88F mutant H4 should show negative results

  • Positive Controls: Cells treated with growth factors known to activate ACK1 (e.g., IGF, PDGF) should show increased signal

  • Knockdown Controls: ACK1 knockdown or knockout cells should show reduced signal

  • Isotype Control: Use of an isotype-matched non-specific antibody to assess background binding

  • Technical Replicates: Multiple replicates to ensure reproducibility

How can HIST1H4A (Ab-88) Antibody be integrated with other methodologies to study chromatin structure?

HIST1H4A (Ab-88) Antibody can be effectively combined with other methodologies to provide comprehensive insights into chromatin structure and function:

  • HiChIP Applications: The antibody can potentially be used in HiChIP experiments to identify chromatin interactions associated with pY88-H4 marks, similar to approaches used with other histone modifications like H3K27ac

  • Multi-omics Integration: Data from pY88-H4 ChIP-seq can be integrated with RNA-seq, ATAC-seq, and other histone modification ChIP-seq datasets to comprehensively map the regulatory landscape

  • Allele-Specific Analysis: For studies involving genetic variants, the antibody could be used to assess allele-specific deposition of pY88-H4 marks, potentially contributing to interaction QTL (iQTL) studies

  • Time-Course Experiments: The antibody can be used to monitor dynamic changes in pY88-H4 deposition following various stimuli, providing insights into temporal regulation

How should researchers address potential cross-reactivity with other histone modifications?

While the HIST1H4A (Ab-88) Antibody has been shown to be highly specific, researchers should consider the following strategies to address potential cross-reactivity concerns:

  • Histone Peptide Array: Comprehensive testing against multiple histone modifications to confirm specificity

  • Point Mutation Studies: Expression of mutant histones (e.g., Y88F-H4) as negative controls

  • Comparison with Total H4: Parallel analysis with antibodies against unmodified H4 to normalize for total H4 levels

  • Multiple Antibody Validation: Confirmation of key findings using alternative antibodies or detection methods when available

  • Mass Spectrometry Validation: For critical findings, mass spectrometry-based validation of the modification can provide definitive evidence

What are the best practices for quantifying pY88-H4 levels in experimental settings?

For accurate quantification of pY88-H4 levels:

  • Western Blot Quantification: Normalization to total H4 levels is essential for comparative analysis

  • ChIP-qPCR: Standard curves should be generated for accurate quantification, with normalization to input DNA

  • ChIP-seq Analysis: Quantification of peak heights or areas using appropriate bioinformatic tools, with normalization to sequencing depth and input controls

  • Statistical Analysis: Multiple biological replicates (minimum n=3) should be used for statistical comparisons

  • Dose-Response Studies: For treatment effects, full dose-response curves rather than single-dose experiments provide more robust quantification

How can researchers distinguish between direct and indirect effects of pY88-H4 on gene regulation?

Distinguishing direct from indirect effects requires multiple complementary approaches:

  • Temporal Analysis: Time-course experiments to determine the sequence of events following stimulation

  • Proximity Analysis: ChIP-seq combined with RNA-seq to correlate pY88-H4 deposition with changes in nearby gene expression

  • Perturbation Studies: Targeted disruption of the modification (e.g., by expressing Y88F-H4 mutant) coupled with gene expression analysis

  • Mechanistic Studies: Investigation of protein complexes recruited to pY88-H4 marks using techniques like ChIP-MS or protein-protein interaction studies

  • Functional Genomics: CRISPR-based editing of potential pY88-H4 binding sites to assess functional consequences

What are the potential applications of HIST1H4A (Ab-88) Antibody in studying chromatin looping and 3D genome organization?

Recent advances in chromatin interaction studies suggest several potential applications:

  • HiChIP Applications: The antibody could be used for HiChIP experiments to identify chromatin loops associated with pY88-H4 marks, similar to approaches using H3K27ac HiChIP

  • Interaction QTL Studies: Integration with genotype data could identify genetic variants associated with pY88-H4-mediated chromatin interactions

  • Cell Type-Specific Interactions: Comparison of pY88-H4-associated chromatin loops across different cell types could reveal tissue-specific regulatory mechanisms

  • Dynamic Reorganization: Analysis of changes in pY88-H4-associated loops in response to stimuli could provide insights into dynamic genome reorganization

How might pY88-H4 interact with other histone modifications in the epigenetic regulation of gene expression?

Understanding the interplay between pY88-H4 and other histone modifications represents an important research direction:

  • Co-occurrence Analysis: ChIP-seq for multiple modifications to identify patterns of co-occurrence or mutual exclusivity

  • Sequential ChIP: Sequential ChIP experiments (Re-ChIP) to determine if pY88-H4 co-exists with other modifications on the same nucleosomes

  • Enzymatic Crosstalk: Investigation of how pY88-H4 might influence the activity of other histone-modifying enzymes

  • Modification Readers: Identification of proteins that specifically recognize pY88-H4 and how they might interact with readers of other modifications

  • Integrative Analysis: Computational integration of multiple histone modification datasets to identify combinatorial patterns associated with specific gene expression states

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.